Skip to main content

Articles

Page 28 of 33

  1. Blood platelets play an essential role in hemostasis, thrombosis and coagulation of blood. Beyond these classic functions their involvement in inflammatory, neoplastic and immune processes was also investigate...

    Authors: József Bódis, Szilárd Papp, István Vermes, Endre Sulyok, Péter Tamás, Bálint Farkas, Katalin Zámbó, Ioannis Hatzipetros and Gábor L Kovács
    Citation: Journal of Ovarian Research 2014 7:55
  2. Ovarian hyperstimulation syndrome (OHSS) is the most serious complication of IVF/ICSI therapy. The pathophysiology and etiology of the disease is still not fully clarified.

    Authors: Kazem Nouri, Peter Haslinger, Ladislaus Szabo, Michael Sator, Martin Schreiber, Christian Schneeberger and Detlef Pietrowski
    Citation: Journal of Ovarian Research 2014 7:54
  3. Amplified centrosomes in cancers are recently garnering a lot of attention as an emerging hub of diagnostic, prognostic and therapeutic targets. Ovarian adenocarcinomas commonly harbor supernumerary centrosome...

    Authors: Shrikant Pawar, Shashikiran Donthamsetty, Vaishali Pannu, Padmashree Rida, Angela Ogden, Nathan Bowen, Remus Osan, Guilherme Cantuaria and Ritu Aneja
    Citation: Journal of Ovarian Research 2014 7:53
  4. Menopause results in a lack of regular menstrual cycles, leading to the reduction of estrogen production. On the other hand, ovarian androgen synthesis is still present at reduced levels and requires expressio...

    Authors: Agnieszka Brodowska, Jacek Brodowski, Maria Laszczyńska, Sylwia Słuczanowska-Głąbowska, Bogdan Rumianowski, Iwona Rotter, Andrzej Starczewski and Mariusz Z Ratajczak
    Citation: Journal of Ovarian Research 2014 7:52
  5. Several adverse effects have been related to infertility treatments, such as cancer development. In particular, the relationship between infertility, reproductive strategies, and risk of gynecological cancers ...

    Authors: Federica Tomao, Giuseppe Lo Russo, Gian Paolo Spinelli, Valeria Stati, Alessandra Anna Prete, Natalie Prinzi, Marsela Sinjari, Patrizia Vici, Anselmo Papa, Maria Stefania Chiotti, Pierluigi Benedetti Panici and Silverio Tomao
    Citation: Journal of Ovarian Research 2014 7:51
  6. Borderline tumors of the ovary (BOT) are a distinct entity of ovarian tumors, characterized by lack of stromal invasion. Recent studies postulated that the presence of invasive implants, incomplete staging, fe...

    Authors: Elena Ioana Braicu, Toon Van Gorp, Mani Nassir, Rolf Richter, Radoslav Chekerov, Khayal Gasimli, Dirk Timmerman, Ignace Vergote and Jalid Sehouli
    Citation: Journal of Ovarian Research 2014 7:49
  7. Despite the increased rate of complete response to initial chemotherapy, most patients with advanced ovarian cancer relapse and succumb to progressive disease. Dendritic cell (DC)-based immunotherapy has been ...

    Authors: Masanori Kobayashi, Asako Chiba, Hiromi Izawa, Eri Yanagida, Masato Okamoto, Shigetaka Shimodaira, Yoshikazu Yonemitsu, Yuta Shibamoto, Noboru Suzuki and Masaki Nagaya
    Citation: Journal of Ovarian Research 2014 7:48
  8. Estrogens are important factors in the female reproductive functions and are processed by a number of enzymes along their metabolic pathway. The COMT gene constitutes a crucial element in estrogen metabolism and ...

    Authors: Emerson Barchi Cordts, Monise Castro Santos, Carla Peluso, Erika Azuma Kayaki, Bianca Bianco, Caio Parente Barbosa and Denise Maria Christofolini
    Citation: Journal of Ovarian Research 2014 7:47
  9. Hyperandrogenism is the primary manifestation of polycystic ovary syndrome (PCOS), which appears to be caused by excess exposure to androgen. As such, androgenized animal models have been developed and investi...

    Authors: Keiko Ikeda, Tsuyoshi Baba, Miyuki Morishita, Hiroyuki Honnma, Toshiaki Endo, Tamotsu Kiya and Tsuyoshi Saito
    Citation: Journal of Ovarian Research 2014 7:46
  10. Antiprogestin compounds have been shown to be effective in blocking the growth of ovarian cancer cells of different genetic backgrounds. Herein we studied the anti-ovarian cancer effect of a series of antiprog...

    Authors: Carlos D Gamarra-Luques, Maria B Hapon, Alicia A Goyeneche and Carlos M Telleria
    Citation: Journal of Ovarian Research 2014 7:45
  11. In mammals, the Tribbles family includes widely expressed serine-threonine kinase-like proteins (TRIB1, TRIB2 and TRIB3) that are involved in multiple biological processes including cell proliferation and fatty a...

    Authors: Daphné Brisard, Franck Chesnel, Sébastien Elis, Alice Desmarchais, Laura Sánchez-Lazo, Manon Chasles, Virginie Maillard and Svetlana Uzbekova
    Citation: Journal of Ovarian Research 2014 7:44
  12. Epithelial ovarian cancer (EOC) has one of the worst prognoses among gynecologic cancers. An appropriate screening method is not available for EOC, and the initial symptoms such as abdominal pain or bloating, ...

    Authors: Kyung-Jin Min, Yung-Taek Ouh, Hye-Ri Hong, Kyeong-A So, Jin Hwa Hong and Jae-Kwan Lee
    Citation: Journal of Ovarian Research 2014 7:43
  13. In this study, we tested the hypothesis that single nucleotide polymorphisms (SNPs) of differentiation-associated human gene icb-1 (C1orf38) may be associated with ovarian cancer susceptibility. For this purpose,...

    Authors: Susanne Schüler, Claus Lattrich, Maciej Skrzypczak, Tanja Fehm, Olaf Ortmann and Oliver Treeck
    Citation: Journal of Ovarian Research 2014 7:42
  14. Studies on the association between obesity and ovarian cancer survival have had conflicting results. We reviewed and quantitatively summarized the existing evidence, exploring potentially important sources of ...

    Authors: Hyo Sook Bae, Hyun Jung Kim, Jin Hwa Hong, Jae Kwan Lee, Nak Woo Lee and Jae Yun Song
    Citation: Journal of Ovarian Research 2014 7:41
  15. Hyaluronic acid is a prognostic factor in ovarian cancers. It is also a component of Hyaluronic Acid-Carboxymethyl Cellulose (HA-CMC) barrier, an anti-adhesion membrane widely used during abdominal surgeries i...

    Authors: Laetitia Picaud, Benoît Thibault, Eliane Mery, Monia Ouali, Alejandra Martinez, Jean-Pierre Delord, Bettina Couderc and Gwenael Ferron
    Citation: Journal of Ovarian Research 2014 7:40
  16. Among the pro-inflammatory lipid mediators, platelet-activating factor (PAF) is a major primary and secondary messenger that binds to the PAF-receptor (PAFR). Epidermal growth factor (EGF) is a polypeptide gro...

    Authors: Yi Yu, Xiaoyan Zhang, Shanshan Hong, Mingxing Zhang, Qingqing Cai, Wei Jiang and Congjian Xu
    Citation: Journal of Ovarian Research 2014 7:39
  17. Gemcitabine (2′, 2′ –difluorodeoxycytidine) is one of many nonplatinum drugs that exhibit activity in recurrent, platinum-resistant ovarian cancer. However, the molecular mechanisms by which Gemcitabine treatm...

    Authors: Hiroshi Kawaguchi, Yoshito Terai, Akiko Tanabe, Hiroshi Sasaki, Masaaki Takai, Satoe Fujiwara, Keisuke Ashihara, Yoshimichi Tanaka, Tomohito Tanaka, Satoshi Tsunetoh, Masanori Kanemura and Masahide Ohmichi
    Citation: Journal of Ovarian Research 2014 7:38
  18. Weight gain and fat accumulation are predisposing factors of PCOS. Life-style modification, including increasing physical activity, is the first line approach in managing PCOS. The objective of this study is t...

    Authors: Maryamosadat Miri, Hojatolah Karimi Jashni and Farzaneh Alipour
    Citation: Journal of Ovarian Research 2014 7:37
  19. A Krukenberg tumor is a rare and potentially deadly cause of elevated serum β-hCG as part of a paraneoplastic syndrome. This study aims to describe the unusual case of a 36-year-old woman that presented to the...

    Authors: Dalia Moghazy, Omar Al-Hendy and Ayman Al-Hendy
    Citation: Journal of Ovarian Research 2014 7:36
  20. Controlled ovarian hyperstimulation (COH) which combining GnRH antagonist co-treatment and GnRH agonist trigger with an additional 1500 IU hCG luteal rescue on day of oocytes retrieval, has become a common too...

    Authors: Jigal Haas, Alon Kedem, Ronit Machtinger, Shir Dar, Ariel Hourvitz, Gil Yerushalmi and Raoul Orvieto
    Citation: Journal of Ovarian Research 2014 7:35
  21. Cryopreservation of the ovarian tissue has shown promising results. However, there remain controversial issues such as the short half-life of grafts. In this aspect, there are some evidences that preconditioni...

    Authors: Luciana Lamarão Damous, Juliana Sanajotti Nakamuta, José Maria Soares-Jr, Gustavo Arantes Rosa Maciel, Ricardo dos Santos Simões, Edna Frasson de Souza Montero, José Eduardo Krieger and Edmund Chada Baracat
    Citation: Journal of Ovarian Research 2014 7:34
  22. Ovarian cystadenocarcinoma is characterized by marked heterogeneity and may be composed of an admixture of histologic growth patterns, including acinar, papillary and solid. In the present study, a case of iso...

    Authors: Fariba Khaki, Javad Javanbakht, Samieh Sharifzad, Mohammad Javad Gharagozlou, Farshid Khadivar, Javad Yaghoobi Yeganeh Manesh, Seyed Hojjat Hosseini, Ali Anissian, Seyed Rashid Touni, Alireza Gilvari and Fatemeh Soghra Abdi
    Citation: Journal of Ovarian Research 2014 7:33

    The Retraction Note to this article has been published in Journal of Ovarian Research 2016 9:76

  23. Polycystic ovarian syndrome (PCOS) is characterized by the presence of multiple follicular cysts, giving rise to infertility due to anovulation. This syndrome affects about 10% of women, worldwide. The exact m...

    Authors: Vineet Kumar Maurya, Chadchan Sangappa, Vijay Kumar, Sahil Mahfooz, Archana Singh, Singh Rajender and Rajesh Kumar Jha
    Citation: Journal of Ovarian Research 2014 7:32
  24. Women with polycystic ovary syndrome (PCOS) have higher risk for cardiovascular disease (CVD). Copeptin has been found to be predictive for myocardial ischemia. We tested whether copeptin is the predictor for ...

    Authors: Basak Karbek, Mustafa Ozbek, Melia Karakose, Oya Topaloglu, Nujen Colak Bozkurt, Evrim Cakır, Muyesser Sayki Aslan and Tuncay Delibasi
    Citation: Journal of Ovarian Research 2014 7:31
  25. Authors: Ospan A Mynbaev, Peter Biro, Marina Yu Eliseeva, Andrea Tinelli, Antonio Malvasi, Ioannis P Kosmas, Mykhailo V Medvediev, Tatiana I Babenko, Madina I Mazitova, Sergei S Simakov and Michael Stark
    Citation: Journal of Ovarian Research 2014 7:29
  26. Ovarian cancer is the most lethal gynecologic disease due to delayed diagnosis, and ascites production is a characteristic of patients in advanced stages. The aim of this study was to perform the proteomic ana...

    Authors: Olga Lilia Garibay-Cerdenares, Verónica Ivonne Hernández-Ramírez, Juan Carlos Osorio-Trujillo, Magdalena Hernández-Ortíz, Dolores Gallardo-Rincón, David Cantú de León, Sergio Encarnación-Guevara, Julio César Villegas-Pineda and Patricia Talamás-Rohana
    Citation: Journal of Ovarian Research 2014 7:27
  27. High expression of the polymeric immunoglobulin receptor (PIGR) has previously been associated with a favourable prognosis in a few cancer forms, but its expression and relationship with clinical outcome in ep...

    Authors: Jonna Berntsson, Sebastian Lundgren, Björn Nodin, Mathias Uhlén, Alexander Gaber and Karin Jirström
    Citation: Journal of Ovarian Research 2014 7:26
  28. Recent studies suggest that ovarian germ line stem cells replenish oocyte-pool in adult stage, and challenge the central doctrine of ‘fixed germ cell pool’ in mammalian reproductive biology. Two distinct popul...

    Authors: Seema Parte, Deepa Bhartiya, Hiren Patel, Vinita Daithankar, Anahita Chauhan, Kusum Zaveri and Indira Hinduja
    Citation: Journal of Ovarian Research 2014 7:25
  29. Polycystic ovary syndrome (PCOS) is associated with an increased cardiovascular disease (CVD) risk and early atherosclerosis. Epicardial adipose tissue thickness (EATT) is clinically related to subclinical ath...

    Authors: Serap Baydur Sahin, Medine Cumhur Cure, Yavuz Ugurlu, Elif Ergul, Emine Uslu Gur, Nese Alyildiz and Mehmet Bostan
    Citation: Journal of Ovarian Research 2014 7:24
  30. The standard treatment of ovarian cancer with chemotherapy often leads to drug resistance and relapse of the disease, and the need for development of novel therapy alternatives is obvious. The MOC31PE immunoto...

    Authors: Merete Thune Wiiger, Hemaseh Bideli, Øystein Fodstad, Kjersti Flatmark and Yvonne Andersson
    Citation: Journal of Ovarian Research 2014 7:23
  31. The aim of our study was to evaluate the behaviour of the human epididymis protein 4 (HE4) in the peritoneal fluid encountered in various female genital diseases.

    Authors: Anita Chudecka-Głaz, Aneta Cymbaluk-Płoska, Janusz Menkiszak, Agnieszka Sompolska-Rzechuła, Elżbieta Byra and Izabella Rzepka-Górska
    Citation: Journal of Ovarian Research 2014 7:22
  32. Polycystic ovary syndrome (PCOS) is characterized by ovarian enlargement, hyperplastic theca compartment and increased androgen production due to, at least in part, excessive expression of several key genes in...

    Authors: Israel Ortega, Jesus A Villanueva, Donna H Wong, Amanda B Cress, Anna Sokalska, Scott D Stanley and Antoni J Duleba
    Citation: Journal of Ovarian Research 2014 7:21
  33. Isolated superficial inguinal metastases without any extended intra-abdominal spread is a rare event in patients with ovarian carcinoma. Here we report an isolated superficial inguinal metastasis in a patient ...

    Authors: Xiao-Jun Yang, Fei-Yun Zheng, Yun-Sheng Xu and Rong-Ying Ou
    Citation: Journal of Ovarian Research 2014 7:20
  34. Tumor-associated macrophages (TAMs) are classified into two major phenotypes, M1 and M2. M1 TAMs suppress cancer progression, while M2 TAMs promote it. However, little is known regarding the role of TAMs in th...

    Authors: Meiying Zhang, Yifeng He, Xiangjun Sun, Qing Li, Wenjing Wang, Aimin Zhao and Wen Di
    Citation: Journal of Ovarian Research 2014 7:19
  35. Low adiponectin levels in polycystic ovarian syndrome (PCOS) have been largely attributed to obesity which is common among these patients. In addition, evidence also suggests that low adiponectin in PCOS may b...

    Authors: Saira Saeed Mirza, Kashif Shafique, Abdul Rauf Shaikh, Naveed Ali Khan and Masood Anwar Qureshi
    Citation: Journal of Ovarian Research 2014 7:18
  36. Endometriosis is characterized by the presence of functional endometrial tissue outside of the uterine cavity. It affects 1 in 10 women of reproductive age. This chronic condition commonly leads to consequence...

    Authors: Doerthe Brueggmann, Claire Templeman, Anna Starzinski-Powitz, Nagesh P Rao, Simon A Gayther and Kate Lawrenson
    Citation: Journal of Ovarian Research 2014 7:17
  37. β-catenin is the key protein in the WNT signalling pathway and it forms adherent junctions together with E-cadherin. In ovarian carcinoma, abnormal expression of β-catenin, E-cadherin and WNT-1 was observed, b...

    Authors: Lubomir Bodnar, Aleksandra Stanczak, Szczepan Cierniak, Marta Smoter, Marzena Cichowicz, Wojciech Kozlowski, Cezary Szczylik, Maciej Wieczorek and Monika Lamparska-Przybysz
    Citation: Journal of Ovarian Research 2014 7:16
  38. The aim of our study is to establish the potential role of dual-phase 18F-fluorodeoxyglucose positron emission tomography / computed tomography (FDG-PET/CT) in patients presenting ovarian masses with diffuse peri...

    Authors: Jae Kwan Lee, Kyung-Jin Min, Kyeong A So, Sungeun Kim and Jin Hwa Hong
    Citation: Journal of Ovarian Research 2014 7:15
  39. miRNAs are proved to have causal roles in tumorgenesis involving various types of human cancers, but the mechanism is not clear. We aimed to explore the effect of miRNAs on the development of ovarian cancer an...

    Authors: Huanchun Ying, Jing Lyu, Tianshu Ying, Jun Li, Shanshan Jin, Jingru Shao, Lili Wang and Hongying Xu
    Citation: Journal of Ovarian Research 2014 7:226

    The Retraction Note to this article has been published in Journal of Ovarian Research 2015 8:17

  40. Epithelial-Mesenchymal Transition (EMT) is a transient and reversible (Mesenchymal-Epithelial Transition or MET) process by which epithelial cells acquire mesenchymal cell characteristics including reduced int...

    Authors: Neda Jabbari, Ashley N Reavis and John F McDonald
    Citation: Journal of Ovarian Research 2014 7:12
  41. The initial dose of recombinant Follicle Stimulating Hormone [rFSH] to be used in assisted reproduction treatment depends on several factors, mainly the cause of the infertility and the patient’s age. For youn...

    Authors: Caio Parente Barbosa, Emerson Barchi Cordts, Andrea Couto Costa, Renato de Oliveira, Marina Acosta de Mendonça, Denise Maria Christofolini and Bianca Bianco
    Citation: Journal of Ovarian Research 2014 7:11
  42. Neovascularization is necessary for follicular growth. Vascularization is first observed in preantral follicles, and thereafter the vasculature markedly increases in follicles undergoing development. Neovascul...

    Authors: Fumie Kizuka-Shibuya, Nobuko Tokuda, Kiyoshi Takagi, Yasuhiro Adachi, Lifa Lee, Isao Tamura, Ryo Maekawa, Hiroshi Tamura, Takashi Suzuki, Yuji Owada and Norihiro Sugino
    Citation: Journal of Ovarian Research 2014 7:10
  43. One of the suggest strategy for patients with repeated implantation failure (RIF) is zygote intrafallopian transfer (ZIFT). However, no data exist regarding to the issue of when and under which circumstances s...

    Authors: Itai Gat, Jacob Levron, Gil Yerushalmi, Jehoshua Dor, Masha Brengauz and Raoul Orvieto
    Citation: Journal of Ovarian Research 2014 7:7

Annual Journal Metrics

  • 2022 Citation Impact
    4.0 - 2-year Impact Factor
    4.7 - 5-year Impact Factor
    1.118 - SNIP (Source Normalized Impact per Paper)
    0.965 - SJR (SCImago Journal Rank)

    2023 Speed
    10 days submission to first editorial decision for all manuscripts (Median)
    138 days submission to accept (Median)

    2023 Usage 
    1,114,260 downloads
    475 Altmetric mentions

New Content ItemEditor-in-Chief Dr Sham Kakar has been recognised as being among the top 2% most-cited researchers in the world. Please join us in celebrating this amazing achievement. 

Read more here.